HUP0000954A3 - Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy - Google Patents

Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy

Info

Publication number
HUP0000954A3
HUP0000954A3 HU0000954A HUP0000954A HUP0000954A3 HU P0000954 A3 HUP0000954 A3 HU P0000954A3 HU 0000954 A HU0000954 A HU 0000954A HU P0000954 A HUP0000954 A HU P0000954A HU P0000954 A3 HUP0000954 A3 HU P0000954A3
Authority
HU
Hungary
Prior art keywords
cardiac
diseases caused
medicinal compositions
treating
hypertrophy
Prior art date
Application number
HU0000954A
Other languages
English (en)
Original Assignee
Daiichi Asubio Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Asubio Pharma Co Ltd filed Critical Daiichi Asubio Pharma Co Ltd
Publication of HUP0000954A2 publication Critical patent/HUP0000954A2/hu
Publication of HUP0000954A3 publication Critical patent/HUP0000954A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU0000954A 1997-02-05 1998-02-05 Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy HUP0000954A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2259497 1997-02-05
PCT/JP1998/000483 WO1998034636A1 (fr) 1997-02-05 1998-02-05 Compositions medicinales pour traiter les cardiopathies induites par l'hypertrophie cardiaque

Publications (2)

Publication Number Publication Date
HUP0000954A2 HUP0000954A2 (hu) 2000-10-28
HUP0000954A3 true HUP0000954A3 (en) 2001-04-28

Family

ID=12087177

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000954A HUP0000954A3 (en) 1997-02-05 1998-02-05 Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy

Country Status (7)

Country Link
EP (1) EP0911034A4 (hu)
KR (1) KR20000064848A (hu)
CN (1) CN1331533C (hu)
AU (1) AU738269B2 (hu)
CA (1) CA2251155A1 (hu)
HU (1) HUP0000954A3 (hu)
WO (1) WO1998034636A1 (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601691B2 (en) 1999-05-17 2009-10-13 Conjuchem Biotechnologies Inc. Anti-obesity agents
AU5043900A (en) * 1999-05-24 2000-12-12 Mayo Foundation For Medical Education And Research Adenovirus vectors encoding brain natriuretic peptide
JP4374419B2 (ja) 2002-10-31 2009-12-02 独立行政法人理化学研究所 多能性幹細胞培養用の組成物とその使用
JP2004224730A (ja) * 2003-01-23 2004-08-12 Univ Nihon ヒト心房性ナトリウム利尿ペプチド含有薬剤
WO2004110489A1 (ja) * 2003-06-13 2004-12-23 Daiichi Asubio Pharma Co., Ltd. Ｔｈ１型免疫疾患予防又は治療用医薬組成物
EP1720562A4 (en) * 2004-01-15 2009-10-28 Scios Inc METHOD FOR TREATING CARDIAL REMODELING AFTER MYOCARDIAL DAMAGE
DE602005026014D1 (de) 2004-07-15 2011-03-03 Univ Queensland Proteinartige verbindungen und anwendungen davon
EP2187953A2 (en) * 2007-09-11 2010-05-26 Mondobiotech Laboratories AG Use of a peptide as a therapeutic agent
DE102010047582A1 (de) * 2010-10-07 2012-04-12 Justus-Liebig-Universität Giessen Stoffe und deren Verwendung zur Beeinflussung natriuretischer Peptidrezeptoren
US9938334B2 (en) 2013-02-15 2018-04-10 Mayo Foundation For Medical Education And Research Insulin secreting polypeptides
CN114350695A (zh) * 2021-12-20 2022-04-15 华南理工大学 一种含二硫键多肽人脑利钠肽hBNP的生产与纯化方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652549A (en) * 1985-01-22 1987-03-24 Merck & Co., Inc. Cardiac anti-hypertrophic agents
IL86386A0 (en) * 1987-05-21 1988-11-15 Merrell Dow Pharma Novel anf derivatives
KR100284247B1 (ko) * 1994-07-18 2001-10-24 다니구치 미즈오 치환티아졸로(3,2,-a)아제핀유도체

Also Published As

Publication number Publication date
AU5780398A (en) 1998-08-26
HUP0000954A2 (hu) 2000-10-28
EP0911034A1 (en) 1999-04-28
KR100839001B1 (hu) 2009-01-12
EP0911034A4 (en) 2004-05-19
AU738269B2 (en) 2001-09-13
CN1219134A (zh) 1999-06-09
CA2251155A1 (en) 1998-08-13
KR20000064848A (ko) 2000-11-06
WO1998034636A1 (fr) 1998-08-13
CN1331533C (zh) 2007-08-15

Similar Documents

Publication Publication Date Title
EP1017379A4 (en) THERAPEUTIC COMPOSITIONS
HK1010364A1 (en) 6-Dimethylaminomethyl-1-phenyl-cyclo-hexane compounds as pharmaceutical agents
HK1009939A1 (en) Medicament for treating cardiac inflammatory diseases
ZA957952B (en) Disinfectant compositions
EP0976407A4 (en) ANTISEPTIC COMPOSITIONS
EP0938901A4 (en) MEDICINAL COMPOSITIONS FOR TREATING HEPATIC CONDITIONS
HUP0000954A3 (en) Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy
HUP0104963A3 (en) Compositions for the treatment of skin diseases
ZA977874B (en) Pharmaceutical compositions for treating viral diseases
EP0790062A4 (en) REMEDY FOR HEART DISEASE
GB2354944B (en) Skin treatment compositions
HUP0003803A3 (en) Use of flunarizine for producing pharmaceutical compositions useful for the topical treating of glaucoma
HU9801925D0 (en) Sodium-hydrogen-change-inhibitors for producing pharmaceutical compositions for treating diseases caused by protozoons
GB9510162D0 (en) Compositions for the treatment of skin conditions
EP0868430A4 (en) THERAPEUTIC COMPOSITIONS
HU9503428D0 (en) Fungicidal compositions for seed treatment
GB2331703B (en) Disinfectant compositions
AU697136B2 (en) Agents for treating metabolic bone diseases
IL120005A0 (en) Pharmaceutical compositions for the treatment of the eye
EP0783891A4 (en) REMEDY FOR BONE DISEASES
GB2345857B (en) Scissors-clip diathermy (SCD)
HUP0003236A3 (en) Medicinal compositions for treating immunodeficiency diseases
GB2308301B (en) New fungicidal compositions
HU9700079D0 (en) Topical compositions for the treatment of skin disease
HUP0001499A3 (en) Use of 7alpha-methyl-17alpha-ethynyl-estrane derivative for producing pharmaceutical compositions for the treatment of atherosclerosis

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: ASUBIO PHARMA CO., LTD., JP

Free format text: FORMER OWNER(S): SUNTORY LIMITED, JP; DAIICHI ASUBIO PHARMA CO., LTD., JP; DAIICHI SUNTORY PHARMA CO., LTD., JP